title: [Treatment effect of breast cancer and prostate cancer on bone].
abstract: Aromatase inhibitors are used in the treatment of breast cancer and androgen deprivation therapy is used in prostate cancer. Both of them induce bone loss and increase fracture incidence. Early detection is important for patients with increased risk of osteoporotic fractures. In this article we review the available treatments and their indication to prevent the onset of osteoporosis and osteoporotic fractures in this patient group.
authors: Servicio de Endocrinología, Hospital Sant Pau i Santa Tecla, Tarragona, Spain. marie_varsa@hotmail.com
authors: Mariela
authors: M
authors: Varsavsky
authors: Sonsoles
authors: S
authors: Guadalix Iglesias
mesh_terms: D000465:Algorithms; D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced*; D058866:Osteoporotic Fractures / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000726:Androgen Antagonists; D047072:Aromatase Inhibitors